Exact Mass: 578.3947

Exact Mass Matches: 578.3947

Found 77 metabolites which its exact mass value is equals to given mass value 578.3947, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PA(10:0/17:0)

[(2R)-3-(decanoyloxy)-2-(heptadecanoyloxy)propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(10:0/17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/17:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of margaric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(8:0/19:0)

[(2R)-2-(nonadecanoyloxy)-3-(octanoyloxy)propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(8:0/19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/19:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of nonadecylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(10:0/a-17:0)

[(2R)-3-(decanoyloxy)-2-[(14-methylhexadecanoyl)oxy]propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(10:0/a-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/a-17:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of anteisoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(10:0/i-17:0)

[(2R)-3-(decanoyloxy)-2-[(15-methylhexadecanoyl)oxy]propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(10:0/i-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-17:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(8:0/i-19:0)

[(2R)-2-[(17-methyloctadecanoyl)oxy]-3-(octanoyloxy)propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(8:0/i-19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-19:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isononadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(a-13:0/i-14:0)

[(2R)-3-[(10-methyldodecanoyl)oxy]-2-[(12-methyltridecanoyl)oxy]propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(a-13:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-14:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-12:0/a-15:0)

[(2R)-2-[(12-methyltetradecanoyl)oxy]-3-[(10-methylundecanoyl)oxy]propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(i-12:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/a-15:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-12:0/i-15:0)

[(2R)-2-[(13-methyltetradecanoyl)oxy]-3-[(10-methylundecanoyl)oxy]propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(i-12:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-15:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-13:0/i-14:0)

[(2R)-3-[(11-methyldodecanoyl)oxy]-2-[(12-methyltridecanoyl)oxy]propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(i-13:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-14:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-14:0/a-13:0)

[(2R)-2-[(10-methyldodecanoyl)oxy]-3-[(12-methyltridecanoyl)oxy]propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(i-14:0/a-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/a-13:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of anteisotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-14:0/i-13:0)

[(2R)-2-[(11-methyldodecanoyl)oxy]-3-[(12-methyltridecanoyl)oxy]propoxy]phosphonic acid

C30H59O8P (578.3947)


PA(i-14:0/i-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/i-13:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   
   

Oleoyl neocryptotanshinone

Oleoyl neocryptotanshinone

C37H54O5 (578.3971)


A diterpenoid with a fatty acyl side chain isolated from Salvia miltiorrhiza and has been shown to inhibit platelet aggregation induced by arachidonic acid.

   

Revandchinone 3

Revandchinone 3

C37H54O5 (578.3971)


   

SCHEMBL8346686

SCHEMBL8346686

C30H58O10 (578.403)


   
   

3beta,21alpha,24-trihydroxyserrat-14-en-3-(4-hydroxybenzoate)

3beta,21alpha,24-trihydroxyserrat-14-en-3-(4-hydroxybenzoate)

C37H54O5 (578.3971)


   

3-O-benzoylpluricostatic acid|3beta-benzoyloxy-2alpha-hydroxy-D:A-friedoolean-28-oic acid

3-O-benzoylpluricostatic acid|3beta-benzoyloxy-2alpha-hydroxy-D:A-friedoolean-28-oic acid

C37H54O5 (578.3971)


   

3beta,21beta,24-trihydroxyserrat-14-en-24-(4-hydroxybenzoate)

3beta,21beta,24-trihydroxyserrat-14-en-24-(4-hydroxybenzoate)

C37H54O5 (578.3971)


   

3beta-vanilloyloxy-stigmast-5-ene-7-one

3beta-vanilloyloxy-stigmast-5-ene-7-one

C37H54O5 (578.3971)


   

PA(12:0/15:0)

1-dodecanoyl-2-pentadecanoyl-glycero-3-phosphate

C30H59O8P (578.3947)


   

PA(13:0/14:0)

1-tridecanoyl-2-tetradecanoyl-glycero-3-phosphate

C30H59O8P (578.3947)


   

PA(14:0/13:0)

1-tetradecanoyl-2-tridecanoyl-glycero-3-phosphate

C30H59O8P (578.3947)


   

PA(15:0/12:0)

1-pentadecanoyl-2-dodecanoyl-glycero-3-phosphate

C30H59O8P (578.3947)


   

PA 27:0

1-tetradecanoyl-2-tridecanoyl-glycero-3-phosphate

C30H59O8P (578.3947)


   

1,1-DIBUTYL-3,3,3,3-TETRAMETHYL-INDADICARBOCYANINE PERCHLORATE

1,1-DIBUTYL-3,3,3,3-TETRAMETHYL-INDADICARBOCYANINE PERCHLORATE

C33H55ClN2O4 (578.385)


   

WURCS=2.0/1,1,0/[hx12xh_3-6_1*OCCOCCCCCCCCCCCCCCCC/6=O_2*OCCO_4*OCCO_5*OCCO]/1

WURCS=2.0/1,1,0/[hx12xh_3-6_1*OCCOCCCCCCCCCCCCCCCC/6=O_2*OCCO_4*OCCO_5*OCCO]/1

C30H58O10 (578.403)


   

NAGlySer 16:3/11:0

NAGlySer 16:3/11:0

C32H54N2O7 (578.3931)


   

NAGlySer 11:0/16:3

NAGlySer 11:0/16:3

C32H54N2O7 (578.3931)


   

2,3-dihydroxypropyl [2-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] hydrogen phosphate

2,3-dihydroxypropyl [2-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] hydrogen phosphate

C30H59O8P (578.3947)


   
   

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C37H54O5 (578.3971)


   

PMeOH 13:0_13:0

PMeOH 13:0_13:0

C30H59O8P (578.3947)


   

PMeOH 12:0_14:0

PMeOH 12:0_14:0

C30H59O8P (578.3947)


   

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

C30H59O8P (578.3947)


   

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

C30H59O8P (578.3947)


   

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate

C30H59O8P (578.3947)


   

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate

C30H59O8P (578.3947)


   

(1-Acetyloxy-3-phosphonooxypropan-2-yl) pentacosanoate

(1-Acetyloxy-3-phosphonooxypropan-2-yl) pentacosanoate

C30H59O8P (578.3947)


   

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) tetracosanoate

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) tetracosanoate

C30H59O8P (578.3947)


   

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate

C30H59O8P (578.3947)


   

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

C30H59O8P (578.3947)


   

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate

C30H59O8P (578.3947)


   

(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) tetradecanoate

(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) tetradecanoate

C30H59O8P (578.3947)


   

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) hexadecanoate

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) hexadecanoate

C30H59O8P (578.3947)


   

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

C30H59O8P (578.3947)


   

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] hexadecanoate

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] hexadecanoate

C30H59O8P (578.3947)


   

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C37H54O5 (578.3971)


   

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C37H54O5 (578.3971)


   

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] heptadecanoate

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] heptadecanoate

C30H59O8P (578.3947)


   

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] hexadecanoate

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] hexadecanoate

C30H59O8P (578.3947)


   

1-dodecanoyl-2-pentadecanoyl-glycero-3-phosphate

1-dodecanoyl-2-pentadecanoyl-glycero-3-phosphate

C30H59O8P (578.3947)


   

1-tridecanoyl-2-tetradecanoyl-glycero-3-phosphate

1-tridecanoyl-2-tetradecanoyl-glycero-3-phosphate

C30H59O8P (578.3947)


   

TG(34:9)

TG(14:1(1)_10:4_10:4)

C37H54O5 (578.3971)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MGDG O-21:0;O

MGDG O-21:0;O

C30H58O10 (578.403)


   

PA O-18:0/9:1;O

PA O-18:0/9:1;O

C30H59O8P (578.3947)


   
   
   
   
   
   
   
   
   
   

(1r,3ar,5r,5ar,5br,7ar,9s,11as,11br,12r,13ar,13bs)-5,9-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-12-yl 4-hydroxybenzoate

(1r,3ar,5r,5ar,5br,7ar,9s,11as,11br,12r,13ar,13bs)-5,9-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-12-yl 4-hydroxybenzoate

C37H54O5 (578.3971)


   

(2s)-2-(3-hydroxy-8,8-dimethyl-1,4-dioxo-6,7-dihydro-5h-phenanthren-2-yl)propyl (9z)-octadec-9-enoate

(2s)-2-(3-hydroxy-8,8-dimethyl-1,4-dioxo-6,7-dihydro-5h-phenanthren-2-yl)propyl (9z)-octadec-9-enoate

C37H54O5 (578.3971)


   

(1r,3ar,5as,6s,7s,9ar,9br,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-3a-hydroxy-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

(1r,3ar,5as,6s,7s,9ar,9br,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-3a-hydroxy-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

C37H54O5 (578.3971)


   

1-(5-ethyl-3-hydroxy-6-methylheptan-2-yl)-3a-hydroxy-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

1-(5-ethyl-3-hydroxy-6-methylheptan-2-yl)-3a-hydroxy-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

C37H54O5 (578.3971)


   

(1r,3as,5as,6s,7s,9ar,9br,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-3a-hydroxy-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

(1r,3as,5as,6s,7s,9ar,9br,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-3a-hydroxy-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

C37H54O5 (578.3971)


   

3-(docosyloxy)-1,8-dihydroxy-6-methylanthracene-9,10-dione

3-(docosyloxy)-1,8-dihydroxy-6-methylanthracene-9,10-dione

C37H54O5 (578.3971)


   

(1r,3ar,5as,6s,7s,9ar,9br,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 4-hydroxybenzoate

(1r,3ar,5as,6s,7s,9ar,9br,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 4-hydroxybenzoate

C37H54O5 (578.3971)


   

2-(3-hydroxy-8,8-dimethyl-1,4-dioxo-6,7-dihydro-5h-phenanthren-2-yl)propyl octadec-9-enoate

2-(3-hydroxy-8,8-dimethyl-1,4-dioxo-6,7-dihydro-5h-phenanthren-2-yl)propyl octadec-9-enoate

C37H54O5 (578.3971)


   

(1r,3ar,5s,5ar,5br,7ar,9s,11as,11br,12r,13ar,13br)-5,9-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-12-yl 4-hydroxybenzoate

(1r,3ar,5s,5ar,5br,7ar,9s,11as,11br,12r,13ar,13br)-5,9-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-12-yl 4-hydroxybenzoate

C37H54O5 (578.3971)


   

1-(5-ethyl-3-hydroxy-6-methylheptan-2-yl)-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 4-hydroxybenzoate

1-(5-ethyl-3-hydroxy-6-methylheptan-2-yl)-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 4-hydroxybenzoate

C37H54O5 (578.3971)


   

5,9-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-12-yl 4-hydroxybenzoate

5,9-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-12-yl 4-hydroxybenzoate

C37H54O5 (578.3971)